Infections and Animals
======================

Infectious diseases have accompanied humankind since its dawn. However, it is not until the end of the last ice age, approximately 10,000 years ago when the agricultural revolution began, that humans became more exposed to the pathogens of infectious disease that have since shaped human history. In the previous era when humans were hunter--gatherers, they moved nomadically over vast territories. Then humans started breeding wild weeds and domesticating animals --sheep, goats, cattle, pigs, poultry, and horses-- for food and labor. Stable settlements and proximity to animals caused pathogens to thrive and spread between animals and humans, and infectious diseases become prominent in influencing life and death (Porter, [@B85]). There began also the sharing of bacterial species between animals and humans, and co-evolution of pathogens with their hosts.

The heritage of the Neolithic Age continues today. It is estimated that over 60% of the emerging human pathogens come from animals (Cutler et al., [@B15]). To feed the growing human population, there is an increasing demand for intensive animal farming involving large numbers of animals, different species in the same area, and the use of growth promoters and antibiotics. These practices can facilitate the emergence of new pathogens, including antibiotic-resistant organisms, and their transmission to humans. In addition, food of animal origin can be a major vehicle for animal pathogens and their spread can be amplified by the market globalization.

From *Staphylococcus aureus* to Methicillin-Resistant *Staphylococcus aureus*
=============================================================================

Staphylococcal infections are of major importance in both human and veterinary medicine. *Staphylococcus aureus* is a major resident or transient colonizer of the skin and the mucosa of humans and primates. It occasionally lives on domestic animals, although these are usually colonized by other species of staphylococci. When *S. aureus* gains entry into the host, it is able to cause a variety of infections, from mild skin infection to life threatening invasive infections.

*Staphylococcus aureus* has the characteristic ability to rapidly develop resistance to virtually any antibiotic drug coming into clinical use (Pantosti et al., [@B83]). Resistance to methicillin -- that indicates resistance to all beta-lactam agents -- was first reported in 1961, the date that marks the appearance of Methicillin-resistant *S. aureus* (MRSA). Methicillin resistance is due to the acquisition of the *mecA* gene, that encodes a new protein designated PBP2a, belonging to a family of enzymes necessary in building the bacterial cell wall. PBP2a has a very low affinity for β-lactam antibiotics and confers resistance to methicillin and the other beta-lactams (Pantosti et al., [@B83]). The *mecA* gene is located on a mobile genetic element, named staphylococcal cassette chromosome *mec* (SCC*mec*) inserted in the *S. aureus* chromosome upstream *orf* X (Katayama et al., [@B53]). Different types of SCC*mec* can be distinguished on the basis of different key elements present, that are the *mec* gene complex, comprising *mecA* and its regulatory genes *mecI* and *mecR1*, and the *ccr* genes complex comprising two different *ccr* recombinases that are responsible for the mobility of the element (Ito et al., [@B47], [@B48]; Ma et al., [@B70]). To date, the website of the International Working Group on the Staphylococcal Cassette Chromosome elements (<http://www.sccmec.org/Pages/SCC_TypesEN.html>, accessed on February 2, 2012) lists 11 types of SCC*mec* elements, originating from the combination of eight different *ccr* genes complex and five different *mec* gene complex.

As MRSA is generated by the introduction of a *mecA*-carrying element in a methicillin-susceptible *S. aureus* (Enright et al., [@B27]), the origin of *mecA* has long been searched for. Couto et al. ([@B10]) found a *mecA* homolog with 80% identity to the *S. aureus* gene in *S. sciuri*, a methicillin-susceptible *Staphylococcus* of rodents, and other primitive mammals. Another *mecA* homolog with 91% identity with *S. aureus mecA* was found in staphylococci recovered from horses, and specifically in *S. vitulinus* (Schnellmann et al., [@B88]). According to recent data, *S. fleurettii*, belonging to *S. sciuri* group, could be the origin of *mecA* as this species contains *mecA* and the chromosomal locus surrounding *mecA* that are almost identical to the corresponding sequence of SCC*mec* (Tsubakishita et al., [@B98]). Taken together, these studies indicate that animal staphylococci are the likely origin and reservoir of *mecA*.

Different types of MRSA
-----------------------

Methicillin-resistant *S. aureus* has long been considered the prototype of multidrug-resistant nosocomial pathogens, causing infections in hospitals and healthcare facilities. The proportion of MRSA infections has increased greatly in the last three decades and strains defined healthcare-associated MRSA (HA-MRSA) have become endemic in industrialized countries as causes of serious infections such as septicemia, pneumonia, ventilator-associated pneumonia, and surgical site infections (Diekema et al., [@B25]). In the US, the National Nosocomial Infections Surveillance System (NNISS) reported that in 2003, over 60% of *S. aureus* isolates in ICUs were MRSA (Klevens et al., [@B57]). In Europe according to data collected by EARS-Net, the rate of MRSA in bloodstream infections ranges from below 1% to over 50% in different countries, with lower rates in North European countries and a higher rate in Mediterranean countries (Kock et al., [@B59]). At the end of the 1990s, a new generation of MRSA appeared suddenly in a different setting, the community. The new MRSA strain, designated community-acquired (CA)-MRSA, is able to cause infections in young and otherwise healthy individuals, showing an unusual virulence and capacity to spread (Deleo et al., [@B20]).

CA-MRSA commonly causes SSTIs with different severity degrees, from mild (furuncles or impetigo), to serious infections (necrotizing fasciitis; Miller et al., [@B72]), and rarely can cause a severe form of pneumonia (necrotizing pneumonia) associated with high mortality (Francis et al., [@B31]). CA-MRSA possesses some distinctive features with regard to HA-MRSA: such as presence of SCC*mec* type IV or type V and rare multi-resistance (Naimi et al., [@B80]). Characteristically, the large majority of CA-MRSA harbors the genes for the Panton--Valentine leukocidin (PVL), a toxin that is absent in HA-MRSA (Vandenesch et al., [@B106]). PVL has been considered the principal virulence determinant (Lina et al., [@B63]; Boyle-Vavra and Daum, [@B7]) or a simple marker of CA-MRSA strains (Voyich et al., [@B112]). In the USA, the increase in the prevalence of CA-MRSA took the shape of an epidemic, largely due to the expansion of a single clone, designated USA300 (Moran et al., [@B78]; Kennedy et al., [@B55]; Tenover and Goering, [@B95]). In Europe, where the prevalence of CA-MRSA infections is lower than in the USA (Del Giudice et al., [@B19]), the most common clone is the European ST80 clone, (Urth et al., [@B99]), alongside a variety of different CA-MRSA clones (Tristan et al., [@B97]; Sanchini et al., [@B87]).

Recently, MRSA emerged as a frequent colonizer of animal populations, possibly favored by the large antibiotic use in animals. In food animals, primarily in pigs, a new MRSA strain with zoonotic potential has been recognized and designated livestock-associated (LA)-MRSA. The following chapters illustrate the association between MRSA and animals and the implications for human health.

*Staphylococcus aureus* as an Animal-Adapted Pathogen
=====================================================

The ability to colonize and produce infections in different hosts, including humans, is an important characteristic of some *S. aureus* lineages. In early studies, the available methods to type *S. aureus* were exclusively phenotypic (phage typing, biotyping, and typing of enzymes or toxins). Nevertheless, they allowed the differentiation of *S. aureus* strains into host specific subsets or ecovars, typically associated with man, poultry, sheep, goats, and cattle (Devriese, [@B22]), while a minority of *S. aureus* strains belonged to non-host specific types and were shared among different hosts. The application of molecular biology techniques confirmed these early findings, revealing that particular genetic backgrounds (clones or lineages) are associated with specific mammalian hosts (Sung et al., [@B94]; Cuny et al., [@B11]). These studies also showed that some lineages are not restricted and can be found to colonize or cause infections in a broad variety of animal species, including humans. One notable example is represented by ST398, originally defined the "pig" clone that has been recovered also from other food animals and from humans (Voss et al., [@B111]; Witte et al., [@B119]). Some primarily "human" clones are often found in animals: ST1, a frequent clone in human infections (Grundmann et al., [@B36]) can cause bovine mastitis (Juhasz-Kaszanyitzky et al., [@B50]) and is carried by pigs in Italy and other European countries (European Food Safety Authority, [@B28]; Franco et al., [@B32]).

*Staphylococcus aureus* adapts specifically to different animal hosts by genetically determined mechanisms that are just starting to be understood. In some cases, host specificity is determined by a selective affinity of certain bacterial receptors to proteins of the preferred host. *S. aureus* acquires iron, an essential bacterial nutrient, from hemoglobin, following lysis of blood red cells produced by *S. aureus* hemolysin. Hemoglobin is released and bound to a surface *S. aureus* receptor, the iron surface determinant B (IsdB), before being degraded. This receptor has a higher affinity for human hemoglobin than for the hemoglobin of other mammals. This explains, at least in part, why *S. aureus* thrives in the presence of human blood and why humans are generally the preferential host for *S. aureus* (Pishchany et al., [@B84]).

Recent phylogenetic studies revealed that some animal *S. aureus* lineages derived from human lineages. In this host-jump, *S. aureus* underwent genetic adaptation losing virulence factors that were useless in the new host and acquiring new characteristics. Some examples are depicted in Table [1](#T1){ref-type="table"}.

###### 

**Distribution of some *S. aureus* genes among human and animal strains**.

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Gene           Function                                                                      Effect                               Presence/absence in isolates from   Reference                                          
  -------------- ----------------------------------------------------------------------------- ------------------------------------ ----------------------------------- -------------------------------------------------- ------------------------------
  *spa*          FC binding                                                                    Impairment of antibody function      P                                   A[°](#tfn1){ref-type="table-fn"} (poultry), ST5\   Lowder et al. ([@B69]),\
                                                                                                                                                                        A[°](#tfn1){ref-type="table-fn"} (cattle), ST151   Herron-Olson et al. ([@B44])

  *chp*          Chemotaxis inhibitor                                                          Impairment of host native immunity   P                                   A (poultry), ST5\                                  Lowder et al. ([@B69]),\
                                                                                                                                                                        A (cattle), ST151                                  Monecke et al. ([@B75]),\
                                                                                                                                                                                                                           Sung et al. ([@B94])

  *scn*          Complement inhibitor                                                          Impairment of host native immunity   P                                   A (poultry), ST5\                                  Lowder et al. ([@B69]),\
                                                                                                                                                                        A (cattle), ST151                                  Monecke et al. ([@B75]),\
                                                                                                                                                                                                                           Sung et al. ([@B94])

  *sak*          Plasminogen activator                                                         Coagulation of plasma                P                                   A (cattle), ST151\                                 Lowder et al. ([@B69]),\
                                                                                                                                                                        A (poultry, pigs), ST1                             Monecke et al. ([@B75]),\
                                                                                                                                                                                                                           Sung et al. ([@B94]),\
                                                                                                                                                                                                                           Franco et al. ([@B32])

  *vWbp^Sov2^*   von Willebrand factor-binding (coagulase)[^\^^](#tfn2){ref-type="table-fn"}   Coagulation of plasma                A                                   P (ruminants), CC133                               Guinane et al. ([@B38])
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

*P, present; A, absent*.

*°Gene disrupted or pseudogene*.

*^\^^Ruminant variant*.

The poultry ST5 lineage which spread in poultry farms world-wide (Lowder et al., [@B69]) has only recently diverged from the human ST5 lineage. This host switch was associated with loss of expression of several proteins that are relevant to human, but not to avian pathogenesis, including the immune evasion cluster and the staphylococcal protein A (SpA). SpA plays a major role in the pathogenesis of human staphylococcal infections; among several functions it binds the FC fragment of human IgG impairing antibody functions, but it does not bind the FC fragment of IgY, the avian analog of IgG. On the other hand, poultry ST5 has acquired novel mobile genetic elements that encode for advantageous traits for survival in an avian host, including resistance to avian phagocytes killing. Similarly, the pathogenic lineage CC133 established in small ruminants (sheep and goats) derived from human *S. aureus* through a combination of allelic diversification, gene decay, and acquisition of mobile genetic elements (Guinane et al., [@B38]). In particular, through horizontal gene transfer, this clone acquired a pathogenicity island (SaPI) encoding a novel variant of the von Willebrand factor-binding protein that has ruminant-specific coagulase activity (Viana et al., [@B110]).

In line with these findings, a microarray study (Sung et al., [@B94]) revealed differences in the frequency of specific genes carried by animal *S. aureus* and those carried by human isolates. In animal isolates, there was a low prevalence of a cluster of genes encoding proteins relevant for host immune evasion that target specifically human immune responses (van Wamel et al., [@B105]). One such gene is *sak*, coding for staphylokinase, a fibrin-specific plasminogen activator that is present in over 80% of human isolates, but is absent from some cattle and pig lineages (Monecke et al., [@B75]; Sung et al., [@B94]; Franco et al., [@B32]).

MRSA in Companion Animals
=========================

In industrialized countries, companion animals have become an integral part of the household. More than 50% of households in the USA have pets and 25% of households in the United Kingdom have dogs (Chomel and Sun, [@B8]). In general, MRSA strains recovered from companion animals (cats, dogs, or horses) are different from those recovered from food animals. In the first case strains are usually similar to human HA-MRSA, while in the second case they appear to belong to specific animal-adapted clones, unrelated to the most common HA-MRSA (Table [2](#T2){ref-type="table"}).

###### 

**Principal MRSA clones shared between animals and humans**.

  Lineage   Clone[\*](#tfn3){ref-type="table-fn"}   Companion animals   Horses   Pigs   Poultry   Cattle   Humans   Reference
  --------- --------------------------------------- ------------------- -------- ------ --------- -------- -------- ----------------------------------------------------------------------------------------------------------------------------------------------------------
  CC1       ST1                                                                  ●                ●        ●        Juhasz-Kaszanyitzky et al. ([@B50]), Cuny et al. ([@B14]), Franco et al. ([@B32])
  CC5       ST5 (USA100)                            ●                            ●      ●         ●        ●        Khanna et al. ([@B56]), Hata et al. ([@B43]), Hasman et al. ([@B42]), McDougal et al. ([@B71])
  CC8       ST8 (USA500)                                                ●                                  ●        Morgan ([@B79]), McDougal et al. ([@B71])
            ST254                                                       ●                                           Cuny et al. ([@B14])
  CC9       ST9                                                         ●        ●                                  European Food Safety Authority ([@B28]), Cuny et al. ([@B14]), Battisti et al. ([@B4])
  CC22      ST22 (EMRSA-15)                         ●                                                      ●        Loeffler et al. ([@B64]), Ellington et al. ([@B26])
            ST36 (EMRSA-16)                         ●                                                      ●        Loeffler et al. ([@B64]), Ellington et al. ([@B26])
  CC97      ST97                                                                 ●                         ●        Battisti et al. ([@B4]), European Food Safety Authority ([@B28]), Gomez-Sanz et al. ([@B35]), Monecke et al. ([@B74])
  CC130     ST130                                                                                 ●        ●        Cuny et al. ([@B12]), Garcia-Alvarez et al. ([@B33]), Shore et al. ([@B90])
  CC398     ST398\*                                 ●                   ●        ●      ●         ●        ●        Loeffler et al. ([@B65]), Cuny et al. ([@B14]), de Neeling et al. ([@B18]), Nemati et al. ([@B81]), Vanderhaeghen et al. ([@B107]), Kock et al. ([@B60])

*\*Principal ST encountered, including also single and double locus variants. The dot means present*.

Other staphylococcal species that share with *S. aureus* the ability to acquire methicillin resistance, specifically *S. intermedius*, *S*. *pseudintermedius*, and *S. schleiferi*, are more common in pets (Hanselman et al., [@B39], [@B41]). Reports of MRSA isolated from pets were sporadic until the late 1990s and were mostly related to clinical infections. In addition, before the identification of *S. intermedius* and *S. pseudintermedius*, some misclassification may have occurred (Devriese et al., [@B24]). The emergence of CA-MRSA in the last decade and the importance of tracing antibiotic-resistant organisms also in the community, have prompted many studies on MRSA in pets and its possible transmission to pet owners.

According to studies performed in various countries, especially in the UK and Australia, MRSA colonization is rare in healthy pets. No MRSA was found in healthy cats in several studies (Baptiste et al., [@B3]; Loeffler et al., [@B64]; Hanselman et al., [@B41]), although in a recent study 2.1% of cats presented to veterinary clinics in Greater London area were colonized by MRSA (Loeffler et al., [@B67]). In dogs in a household or at admission to a veterinary hospital, colonization rates varied from 0 to 2.1% (Bagcigil et al., [@B2]; Boost et al., [@B6]; Hanselman et al., [@B39], [@B41]; Loeffler et al., [@B67]). In some particular settings, e.g., dogs in a rescue shelter (Loeffler et al., [@B68]) or in a veterinary hospital (Loeffler et al., [@B64]), a high MRSA colonization rate, up to 9%, was found.

Methicillin-resistant *S. aureus* infections in pets are mainly represented by skin and soft tissue infections and are sometimes associated with veterinary surgeries. In a large study in the UK, MRSA was recovered from 1.5% of samples from infected animals (Rich and Roberts, [@B86]). In several studies, dogs appear to have more MRSA infections than cats (Morgan, [@B79]), but as there are no direct comparative studies, any implication of different susceptibility to MRSA infections between these animal species should be verified. The MRSA types recovered from cats and dogs are similar to those affecting humans, with a similar regional distribution (Table [2](#T2){ref-type="table"}). For instance, in the USA the most common MRSA type in pets is the clone identified as USA100 (ST5), which is also the most common HA-MRSA clone in humans (McDougal et al., [@B71]). In the United Kingdom the most common clones are those identified as EMRSA-15 (ST22) and EMRSA-16 (ST36) that are prevalent in UK hospitals (Ellington et al., [@B26]). Recently, dogs have been found to be colonized by the livestock-associated (LA)-MRSA clone characteristic of food animals and identified as ST398 (Loeffler et al., [@B65]).

Horses are colonized by MRSA in a percentage ranging from 0 to 11% (Vengust et al., [@B109]; Bagcigil et al., [@B2]; Loeffler et al., [@B67]). In a large study of colonization in Canada involving over 2,000 horses, 2.7% were found to be colonized by MRSA, mainly intranasally (Weese et al., [@B117]) while studies performed at equine hospitals showed a higher rate (Baptiste et al., [@B3]). Sporadic cases and outbreak of MRSA infections in horses were reported in large establishments or post-operatively in veterinary hospitals (Weese et al., [@B117]; Morgan, [@B79]).

Horses, differently from pets, are colonized or infected by MRSA types quite different from the lineages predominant in humans in the corresponding areas (Loeffler and Lloyd, [@B66]). Horse MRSA commonly belong to ST8 and related STs within clonal complex (CC) 8. A typical horse clone is USA500 (Morgan, [@B79]), that emerged as an HA-MRSA clone in the USA but is now infrequently recovered in human patients (McDougal et al., [@B71]). More recently, studies from Europe and Canada reported horses to be colonized by LA-MRSA ST398 (Cuny et al., [@B14]; Tokateloff et al., [@B96]; Table [2](#T2){ref-type="table"}).

Transmission of MRSA between humans and companion animals
---------------------------------------------------------

Transmission of bacterial strains between companion animals and their owners has been demonstrated in several instances. Molecular analyses have shown the presence of indistinguishable MRSA strains in pets and humans living in the same household, and have suggested, but not definitely proved, the direction of transmission (Weese, [@B115]). As the isolates from cats and dogs resemble nosocomial MRSA, it is usually assumed that companion animals acquire MRSA from humans. Both humans and animals are more often colonized than infected and both can act as reservoirs of MRSA for recirculation of strains inside the household (Morgan, [@B79]). According to a study performed in Canada and in the US, the owners of companion animals have a MRSA colonization rate (18%) significantly higher than the general population (1--2%) although they do not appear to be at an increased risk for MRSA infections (Faires et al., [@B29]). In a nursing home for the elderly in UK patients, staff, and the resident cat were all colonized by the same MRSA strain. The cat harbored the MRSA strain on the fur and paws and was the most probable vehicle of MRSA transmission in the nursing home (Scott et al., [@B89]). In a veterinary hospital the transmission of an EMRSA-15 (ST22) strain from infected dogs to staff members has been demonstrated by molecular typing methods (Baptiste et al., [@B3]). Pets can be also colonized by CA-MRSA, as the spread of a PVL-positive CA-MRSA strain in a household in the Netherlands was shown to involve also the family dog (van Duijkeren et al., [@B103]).

Methicillin-resistant *S. aureus* transmission from horses to humans (and sometimes vice-versa) is also well documented, especially with regard to professionals caring for infected animals in veterinary hospitals. Staff caring for an MRSA-infected foal experienced skin infections due to the characteristic equine strain USA500, the same carried by the foal (Weese et al., [@B116]).

MRSA in Food Animals: LA-MRSA ST398
===================================

In 2004, a baby and her parents who lived on a pig farm in the Netherlands were unexpectedly found to be colonized by MRSA. Other pig farmers and their close contacts, as well as one pig were found colonized (Voss et al., [@B111]). The colonization rate in pig farmers was found to be 23%, a figure 100 times higher than the normal colonization rate in the Netherlands. All MRSA isolates were found to share similar characteristics, such as non-typeability by PFGE and identical *spa* type. Similar findings in pigs and pig farmers were reported from France (Armand-Lefevre et al., [@B1]). The "pig MRSA" was found to belong to a unique MRSA clone, ST398, and to a group of related *spa* types.

Subsequent studies demonstrated that the presence of the "pig MRSA" in the Netherlands and France was not an exceptional occurrence, as this clone was recovered from pigs in several European countries (Guardabassi et al., [@B37]; Vanderhaeghen et al., [@B108]). In addition, MRSA ST398 was shown to colonize other species of livestock besides swine (Table [2](#T2){ref-type="table"}); it was thus more appropriately designated LA-MRSA. The reported carriage rates of LA-MRSA ST398 in pigs varied according to the geographical area and the type of study: from 1% in Denmark (Guardabassi et al., [@B37]), to 40% in Belgium and the Netherlands (de Neeling et al., [@B18]; Vanderhaeghen et al., [@B108]).

In a study funded by the European Food Safety Agency (EFSA), conducted in 2008, 24 European countries were involved in an active survey of MRSA in the dust of the environment of pig holdings as an indication of pig colonization. Overall, MRSA were found in pig holdings of 17 countries, with a prevalence varying between countries from 1 to 50% of the holdings sampled. Generally, countries with a higher density of pig farming were also countries with a higher recovery rate of MRSA (European Food Safety Authority, [@B28]). In this survey, *spa* types related to ST398 were, as expected, largely dominant; however, different clones, such as ST1, ST9, and ST97, were also found associated with pig carriage, although at a much lower frequency (Figure [1](#F1){ref-type="fig"}).

![***spa* types of MRSA isolated from pig production holdings in Europe, their genetic relationship, and association with ST398 and with less frequent CCs**. Size and color of each circle correspond to the prevalence of the *spa* type indicated, from red (most frequent) to pale blue (less frequent). Reproduced from the EFSA J. with permission (European Food Safety Authority, [@B28]).](fmicb-03-00127-g001){#F1}

The presence of LA-MRSA ST398 in pigs is not exclusive to Europe, as a high rate of ST398 colonization was also found in pigs in Canada (Khanna et al., [@B56]) and in the US (Smith et al., [@B91]).

Other MRSA clones besides ST398 have been found to colonize pigs, generally with a regional distribution (Table [2](#T2){ref-type="table"}). Studies performed in China reported the presence of ST9 colonizing pigs and workers (Wagenaar et al., [@B113]). In other areas, common human clones were identified in pigs, such as USA100 (ST5) in Canada (Khanna et al., [@B56]) and recently, ST22 in Ireland (Horgan et al., [@B45]). In Italy, pigs at the slaughterhouse were found to be colonized by different clones of MRSA besides ST398, including t127/ST1, ST9, and ST97 (Battisti et al., [@B4]). ST1 is a common human clone, although it is frequently recovered in Italian hospitals in recent years (Monaco et al., [@B73]). It is possible that the recovery of human clones in pigs represents human-to-pig contamination, but it is also possible that some strains, such as the t127/ST1 clone are in fact animal-adapted strains of ancient human origin.

Despite the high rate of colonization in pigs, LA-MRSA ST398 has only sporadically been reported to cause clinical infections in this animal species (Weese, [@B115]): in pigs infections are rarely caused by *S. aureus*, the most common staphylococcal pathogen being *S. hyicus*.

The contamination of food products by animal MRSA is a big threat, as it has a potential for wide dissemination in the general population (Kluytmans, [@B58]). A study performed in the Netherlands found that 11% of raw meat samples from the retail market (including pork, beef, veal, lamb, and chicken) was contaminated by MRSA, represented mainly by MRSA ST398 (de Boer et al., [@B17]). A study from South Italy reported the presence of MRSA of *spa* types corresponding to ST398 in mozzarella cheese products (Crisetti et al., [@B16]).

LA-MRSA ST398 has been isolated not only from pigs, but also from other animal species, as already mentioned, including dogs, horses, calves, and poultry (Cuny et al., [@B14]; Hasman et al., [@B42]; Huber et al., [@B46]; Loeffler and Lloyd, [@B66]). In a study from Belgium, 12% of the isolates obtained in 2006 from healthy chickens were MRSA that belonged to *spa* types associated with ST398 (Nemati et al., [@B81]; Table [2](#T2){ref-type="table"}).

Microbiological, molecular, and virulence characteristics of LA-MRSA ST398
--------------------------------------------------------------------------

LA-MRSA strains were initially distinguished by their peculiar resistance to digestion by *Sma*I, the restriction enzyme most frequently used for PFGE typing of *S. aureus* (Chung et al., [@B9]), due to the presence of a new methylation enzyme protecting restriction sites (Bens et al., [@B5]). Otherwise, LA-MRSA were perfectly typeable by current molecular methods: they were associated with a specific group of *spa* types with related repeat sequences, including t011, t034, t108, and t899 (Vanderhaeghen et al., [@B108]; Figure [1](#F1){ref-type="fig"}) and belonged to ST398, a clone historically quite rare in humans that did not derive from the most common MRSA lineages. Characteristically, LA-MRSA ST398 strains carry SCC*mec* type type IV or, more frequently, type V (Monecke et al., [@B74]). The presence of these SCC*mec* types in LA-MRSA is shared with CA-MRSA and suggests a transmission of genetic elements between these two MRSA groups. However, differently from CA-MRSA, ST398 generally does not possess the phage-encoded PVL-genes, that contribute to the virulence of the former. Exceptions involve strains of human infections that may have acquired PVL-genes from human MRSA: one patient from the Netherlands and two patients from Sweden had infections associated with PVL-positive ST398 (van Belkum et al., [@B100]; Welinder-Olsson et al., [@B118]). Also sporadic ST398 MRSA from China has been found to be PVL-positive (Yu et al., [@B122]; Stegger et al., [@B93]). No specific virulence factor characteristic of ST398 has been identified so far (Monecke et al., [@B74]).

LA-MRSA ST398 is generally susceptible to antibiotics other than beta-lactams, but it is characteristically resistant to tetracycline, which suggests that heavy tetracycline use in the pig industry may have favored the emergence of this clone. A recent study showed that the addition of tetracycline or zinc in animal feed increased the number of ST398 bacterial cells in pigs' nostrils although it had no effect on MRSA transmission (Moodley et al., [@B76]). LA-MRSA ST398 strains have been found to carry previously unidentified resistance genes, such as a novel trimethoprim resistance gene, *dfrK*, (Kadlec and Schwarz, [@B52]) and a novel gene, *vga*(C), encoding an ABC efflux pumps and conferring resistance to streptogramins and lincosamides (Kadlec and Schwarz, [@B51]). In addition, an isolate from the nose of a pig was found to carry the multidrug resistance gene *cfr* (Kehrenberg et al., [@B54]) that is able to confer resistance to five different antibiotic classes, including linezolid, a "last-resource" antibiotic for serious infections due to multidrug-resistant Gram-positive bacteria. Due to their characteristic multi-host specificity, ST398 strains can represent an efficient vehicle of these resistant determinants that are plasmid-encoded, favoring their transmission and spread.

LA-MRSA ST398 carriage and infections in humans
-----------------------------------------------

Before the "epidemic" of pig colonization, ST398 isolates were rarely reported from human colonization or infection. After the first report from the Netherlands, many studies from Europe and other areas indicated that living or working on a farm was a risk factor for acquiring MRSA (Table [3](#T3){ref-type="table"}). A case-control study performed in the Netherlands showed that carriers of non-typeable MRSA were more often pig or cattle farmers and that the density of non-typeable MRSA isolates corresponded to the density of pig farming (van Loo et al., [@B104]). In Belgium 37.8% of pig farmers were found colonized by ST398 (Denis et al., [@B21]); in Germany 86% of pig farmers and 45% of veterinarians caring for pigs were colonized (Cuny et al., [@B13]). Family members that were not directly exposed to pigs were colonized in a lower percentage (Cuny et al., [@B13]), indicating that inter-human transmission can occur but at low frequency. Veterinarians and other attendees of an international conference on pig health in Denmark were sampled for MRSA carriage and 12.5% were found to carry MRSA that mostly belonged to *spa* types corresponding to ST398 (Wulf et al., [@B120]).

###### 

**Prevalence of MRSA and ST398 MRSA carriage in different healthy populations, in patients, and among clinical isolates**.

  Population                                    Country                              No. of subjects   MRSA    ST398[°](#tfn4){ref-type="table-fn"}   Reference
  --------------------------------------------- ------------------------------------ ----------------- ------- -------------------------------------- --------------------------------
  **CARRIAGE**                                                                                                                                        
  Pig farmers                                   Netherlands                          26                23%     23%                                    Voss et al. ([@B111])
  Veterinarians                                 International (mainly from USA)      345               7.0%    0                                      Hanselman et al. ([@B40])
  Pig veterinarians                             International (mainly from Europe)   235               14.0%   13.1%                                  Wulf et al. ([@B121])
  Veterinarians and veterinary personnel        Czech Republic                       280               0.7%    0                                      Zemlickova et al. ([@B123])
  Veterinarians                                 Belgium                              146               9.5%    7.5%                                   Garcia-Graells et al. ([@B34])
                                                Denmark                              143               1.4%    1.4%                                   
  Pig farmers                                   Belgium                              127               37.8%   37.8%                                  Denis et al. ([@B21])
  Pig farmers[\*](#tfn5){ref-type="table-fn"}   Germany                              113                       86%                                    Cuny et al. ([@B13])
  Family members                                                                     116                       4.3%                                   
  Pig veterinarians                                                                  49                        45%                                    
  Pupils (10--16 years)                                                              462                       \<1%                                   
  Pig workers                                   USA                                  20                45%     45%                                    Smith et al. ([@B91])
  Pig farmers                                   Ireland                              100               2%      0                                      Horgan et al. ([@B45])
  Patients at admission                         Germany                              834               71%     25%                                    Kock et al. ([@B60])
  **CLINICAL SAMPLES**                                                                                                                                
  Clinical MRSA isolates                        Europe                               8,262                     1.7%                                   van Cleef et al. ([@B101])

*°MRSA resistant to *Sma*I digestion or belonging to specific *spa* types are included under ST398*.

*\*Farmers exposed to MRSA-positive pigs*.

In Ontario (Canada), 20% of pig farmers were colonized by MRSA and a correlation was noted between the presence of MRSA in pigs and humans on farms (Khanna et al., [@B56]).

Infection can follow colonization and LA-MRSA ST398 has been found to be associated with human infections (Krziwanek et al., [@B61]), including serious forms such as deep abscesses, cellulitis, necrotizing fasciitis (Pan et al., [@B82]; Soavi et al., [@B92]), and bacteremia (van der Mee-Marquet et al., [@B102]). A survey carried out in 17 European countries in 2007 on the prevalence of ST398 among MRSA isolates from human infections, revealed that the highest proportion of ST398 was found in the Netherlands and in Belgium, while in the other countries the proportion was \<2% (van Cleef et al., [@B101]; Table [3](#T3){ref-type="table"}). A small hospital outbreak due to ST398 occurred in Denmark in 2007 (Wulf et al., [@B120]), indicating that this clone is capable of inter-human spread outside the farming setting, although this phenomenon is currently limited. In a recent study, 25% of patients admitted to a University Hospital in 2008--2009 in a German region with high a density of pig farming carried MRSA of *spa* types associated with ST398 and a number of clinical infections due to this clone were detected (Kock et al., [@B60]). According to a Dutch study, ST398 seems to be less transmittable inside hospitals than non-ST398 MRSA (Wassenberg et al., [@B114]). It could be speculated that the scarce propensity of LA-MRSA to spread in hospitals may be due to its susceptibility to antibiotics other than beta-lactams compared to typical HA-MRSA. However, the possibility that LA-MRSA may acquire other resistant traits and pose a greater risk to the human population cannot be dismissed.

MRSA in Bovine Mastitis
=======================

*Staphylococcus aureus* is one of the most important bacterial pathogens in bovine mastitis, a disease that causes significant economical losses in the milk industry; thus, *S. aureus* in general and MRSA in particular have been the focus of several studies in dairy cattle. The first report of MRSA in bovine mastitis milk comes from Belgium where in 1972 Devriese and Hommez isolated strains that, using biotyping methods, appeared to be of human origin (Devriese and Hommez, [@B23]). After this report, and until recently, MRSA was only sporadically isolated from cow milk. In the Republic of Korea a small proportion (0.4%) of MRSA was found among 3047 bacterial isolates from bovine mastitis milk samples obtained between 1997 and 2004 (Moon et al., [@B77]). In Switzerland MRSA were found in 1.4% of mastitis milk samples (Huber et al., [@B46]) and in Hungary MRSA characterized by *spa* type t127 and ST1, of likely human origin, was recovered in 4% of samples from cows with subclinical mastitis. In this last study, transmission of MRSA to a farmer working in close contact with bovines was also demonstrated (Juhasz-Kaszanyitzky et al., [@B50]). A study from Japan examined 363 *S. aureus* from bovine milk: of these, only four were MRSA, all belonging to CC5 (Hata et al., [@B43]). In Belgium MRSA was found in nearly 10% of the farms where *S. aureus* mastitis was present. This comparatively high prevalence was associated with the finding that all isolates were LA-MRSA ST398 (Vanderhaeghen et al., [@B107]; Table [2](#T2){ref-type="table"}).

Few studies dealt with colonization of healthy cattle: a study from Switzerland only found MRSA in 1% of nasal swabs from calves and in 0.25% of nasal swabs from cattle (Huber et al., [@B46]). In this study the MRSA isolates from calves were ST398, providing evidence that LA-MRSA ST398 can colonize also cattle, although the colonization rate is much lower than in pigs (Table [2](#T2){ref-type="table"}).

A new *mecA* gene in bovine isolates
------------------------------------

A recently published article (Garcia-Alvarez et al., [@B33]) reported the presence of MRSA strains with unusual features in bovine milk samples from the UK. These strains belonged mainly to CC130 (more rarely to CC425) and carried a novel *mecA* gene that was only 70% identical at the nucleotide level to the classical *mecA* gene, escaping detection by routine PCR assays. Similarly, the encoded PBP2a protein was only 63% identical to the classical PBP2a protein and could not be detected by the commercially available antibody-based assays. The novel *mecA* was named *mecA*~LGA251~, after the designation of the bovine strain where it was identified for the first time. In turn *mecA*~LGA251~ was part of a novel SCC*mec* element, identified as type XI. Other distinguished features of the SCC*mec* type XI are the presence of a *mec* complex that has a different organization from other SCC*mec* elements including also the beta-lactamase resistance gene *blaZ*, and the presence of an arsenic resistance operon.

Although previously CC130 had been associated only with methicillin-susceptible *S. aureus* from animals, isolates with the same novel *mecA*~LGA251~ were recovered from human clinical infections in the UK and Denmark. The ability of these strains to cause infections in humans was confirmed by a concurrent report describing two patients infected with similar strains in Ireland (Shore et al., [@B90]) and by another study from Germany where 11 CC130 strains carrying SCC*mec* type XI and *mecA*~LGA251~ were identified out of a collection of 12,691 MRSA obtained in 2006--2011 (Cuny et al., [@B12]).

It is possible that these strains had been circulating for some time among cattle: for instance in 2003 a report from Korea described some MRSA strains from dairy cattle with low-level resistance to oxacillin that were *mecA*-negative (Lee, [@B62]). Studies to investigate these findings further were not performed, but it is plausible to speculate that these strains carried the *mecA*~LGA251~ gene or a similar variant.

The strains with the novel *mecA* are a new example of LA-MRSA. At the moment they do not seem to pose a great risk, but their evolution is unpredictable: they could become better able to colonize, more resistant, or more pathogenic (Fluit, [@B30]). Continuous surveillance is necessary to promptly detect new types of MRSA from animals and to evaluate their impact on human health.

Conclusion
==========

Methicillin-resistant *S. aureus* made its first appearance as the resistant variant of *S. aureus* 50 years ago and has since established as a typical multi-resistant nosocomial pathogen (Jevons, [@B49]). In the last two decades, new generations of MRSA have emerged, with the distinctive ability to occupy new niches, specifically the human community and food-producing animals. The risk of the presence of MRSA in food animals is clearly associated with the transfer of these microorganisms to humans. If these new MRSA enter hospitals, they will find frail patients who will be easily infected.

Phylogenetic studies revealed that some lineages of animal-adapted staphylococci originated from human strains following profound genetic modifications, and that today these animal-adapted strains can be transmitted back to humans. Both wild and food animals are in contact with the large microbiome and resistome pools of the environment and can therefore carry new strains and become their vehicle to the human community. Different staphylococcal species present in animals and the environment represent a large reservoir of resistance genes, from which MRSA has already picked not only the *mec* gene, but also other resistance determinants. The new MRSA from animals may be able to convey to humans novel resistant determinants and novel virulence factors.

While in hospitals the proportion of MRSA is clearly associated with patterns of high antibiotic consumption, it is unclear if the emergence of animal strains has been driven by high or inappropriate antibiotic consumption in the animal farming setting. However, the control of antibiotic use appears to be one of the few possible interventions today to reduce the spread and transmission of MRSA. As for MRSA colonizing food animals, good farming practices also appear to be essential in the control of the spread of MRSA.
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